Impact of Hormone Receptor Status and Tumor Subtypes of Breast Cancer in Young BRCA Carriers
Matteo Lambertini shared a post by Annals of Oncology, on X:
“Presented at ASCO24 by Luca Arecco and now out in Annals of Oncology…really grateful to all that have made the BRCA BCY collaboration possible…another important news for the counseling of young women with Breast Cancer. ”
Quoting Annals of Oncology‘s post:
“New article in press: Impact of Hormone Receptor Status and Tumor Subtypes of Breast Cancer in Young BRCA Carriers.”
Source: Matteo Lambertini/X and Annals of Oncology/X
Matteo Lambertini is an adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital and the University of Genova in Italy. He specializes in managing breast cancer in young women, particularly addressing fertility and pregnancy-related issues post-diagnosis.
Lambertini’s notable research includes using GnRH agonists during chemotherapy to preserve ovarian function and studying the safety of pregnancy after breast cancer. He also serves on the scientific boards of ESMO, ESHRE, and AIOM for fertility preservation in cancer patients.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023